. Le, est appuyé sur une Note déjà transmise au PDG de l'Inserm avant la réunion 2015 des HIROs à Toronto et qui portait sur le débat sur l'opportunité -ou non -d'un moratoire sur les recherches visant à appliquer les techniques d' « édition du génome » de type CRISPRCas9 à des gamètes et embryons humains

, Comité d'éthique de l'Inserm, CIB de l'Unesco et Médecine/Sciences), ces appartenances étant mentionnées car les questions soulevées par la technologie CRISPR ont été d, Médecine/Sciences et Agence de la Biomédecine) et Hervé Chneiweiss (DR1 Cnrs

L. , B. Dupret, and . Pierre-olivier, Angrand Med Sci (Paris), vol.30, pp.186-193, 2014.

, La révolution des CRISPR est en marche Hélène Gilgenkrantz Med Sci (Paris), vol.30, pp.1066-1069, 2014.

. Zetsche, Kiani et al. Cas9 gRNA engineering for genome editing, activation and repression, Nat Methods, 2015.

C. Y. Park, Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons. Cell Rep, 2015.

E. S. Lander, The Heroes of CRISPR, Cell, vol.164, issue.1-2, pp.18-28, 2016.

. Kleinstiver, High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects, Nature, 2016.

. Kleinstiver, Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition, Nat Biotechnol, vol.33, issue.12, pp.1293-1298, 2015.

A. Burt, Site-specific selfish genes as tools for the control and genetic engineering of natural populations, Proceedings of the Royal Society B: Biological Sciences, vol.270, p.921, 1518.

N. Windbichler, M. Menichelli, P. A. Papathanos, S. B. Thyme, H. Li et al., A synthetic homing endonuclease-based gene drive system in the human malaria mosquito, Nature, vol.473, issue.7346, pp.212-215, 2011.

K. M. Esvelt,

A. L. Smidler,

F. ;. Catteruccia, . Church, and M. George, Concerning RNA-guided gene drives for the alteration of wild populations, p.3401, 2014.

J. E. Dicarlo, A. Chavez, S. L. Dietz, K. M. Esvelt, and G. M. Church, The mutagenic chain reaction: A method for converting heterozygous to homozygous mutations, 2015.

. Gantz, Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi, Proc Natl Acad Sci U S A, vol.112, pp.6736-6779, 2015.

. Hammond, A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae, Nat Biotechnol, vol.34, issue.1, pp.78-83, 2016.

. Efsa--guidance, TDR | A new framework for evaluating genetically modified mosquitoes, Efsa.europa.eu, pp.2014-2020

M. Crispo, ):e0120396. Zhong et al. CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes. Sci Rep, Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR-Cas9 Technology and Microinjection into Zygotes, vol.10, pp.3-9, 2014.

R. , Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases

, Genome Res, vol.24, issue.8, pp.1371-83, 2014.

Y. Niu, Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos, Cell, vol.156, issue.4, pp.836-879, 2014.

P. Liang, Y. Xu, X. Zhang, C. Ding, R. Huang et al., CRISPR-Cas9-mediated gene editing in human tripronuclear zygotes, Protein Cell, vol.6, issue.5, pp.363-72, 2015.

«. Practically, there are multiple existing legislative and regulatory prohibitions against this kind of work. The Dickey-Wicker amendment prohibits the use of appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed, p.2880

, It is also important to note the role of the U.S. Food and Drug Administration (FDA) in this arena, which applies not only to federally funded research, but to any research in the U.S. The Public Health Service Act and the Federal Food, Drug, and Cosmetic Act give the FDA the authority to regulate cell and gene therapy products as biological products and/or drugs, which would include oversight of human germline modification. During development, biological products may be used in humans only if an, NIH Guidelines state that the Recombinant DNA Advisory Committee

P. Reddy, A. Ocampo, K. Suzuki, J. Luo, S. R. Bacman et al., Selective elimination of mitochondrial mutations in the germline by genome editing, Cell, vol.161, issue.3, pp.459-69, 2015.

D. Baltimore, P. Berg, M. Botchan, D. Carroll, R. A. Charo et al., A prudent path forward for genomic engineering and germline gene modification, Biotechnology

, Apr, vol.3, issue.6230, pp.36-44

, Proc.Nat.Acad.Sci.USA, vol.72, pp.1981-1984, 1975.